Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis.
Cross-Sectional Studies
Dust
Occupational Health
Respiratory Function Tests
Silicosis
Journal
Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759
Informations de publication
Date de publication:
03 May 2022
03 May 2022
Historique:
received:
20
12
2021
accepted:
18
04
2022
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
4
5
2022
Statut:
aheadofprint
Résumé
To investigate differences in workplace exposure, demographic and clinical findings in engineered stone (ES) workers from a multinational consortium using the Engineered Stone Silicosis Investigators (ESSI) Global Silicosis Registry. With ethics board approval in Israel, Spain, Australia and the USA, ES workers ages 18+ with a physician diagnosis of work-related silicosis were enrolled. Demographic, occupational, radiologic, pulmonary function and silica-related comorbidity data were compared cross-sectionally among countries using analysis of variance, Fisher's exact tests and logistic regression. Among 169 ES workers with silicosis, most were men, with mean age 51.7 (±11.4) years. Mean work tenure in stone fabrication or masonry was 19.9 (±9.8) years. Different methods of case ascertainment explained some inter-country differences, for example, workers in Queensland, Australia with a state-based surveillance program were likely to be identified earlier and with shorter work tenure. Overall, 32.5% of workers had progressive massive fibrosis, the most severe form of dust-related pneumoconiosis, of whom 18.5% reported ≤10 years of work tenure. Lung function impairment including restriction, reduced diffusion capacity and hypoxaemia was common, as was autoimmunity. Findings from a multinational registry represent a unique effort to compare demographic, exposure and clinical information from ES workers with silicosis, and suggest a substantial emerging population of workers worldwide with severe and irreversible silica-associated diseases. This younger worker population is at high risk for disease progression, multiple comorbidities and severe disability. The ESSI registry provides an ongoing framework for investigating epidemiological trends and developing prospective studies for prevention and treatment of these workers.
Identifiants
pubmed: 35504722
pii: oemed-2021-108190
doi: 10.1136/oemed-2021-108190
pmc: PMC9453561
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIEHS NIH HHS
ID : K23 ES030725
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES007033
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008433
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
ERJ Open Res. 2016 Mar 17;2(1):
pubmed: 27730180
Heart. 2010 Jul;96(14):1095-101
pubmed: 20511625
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
J Occup Environ Med. 2009 Feb;51(2):164-9
pubmed: 19209037
Occup Environ Med. 2018 Jan;75(1):3-5
pubmed: 28882991
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):257-60
pubmed: 16850763
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Occup Med (Lond). 2015 Aug;65(6):444-50
pubmed: 26070814
Am J Ind Med. 1993 Oct;24(4):427-45
pubmed: 8250062
Immunobiology. 2012 Jul;217(7):743-8
pubmed: 22226303
Toxicol Sci. 2016 Sep;153(1):4-17
pubmed: 27255382
Eur Respir J. 2021 Mar 11;57(3):
pubmed: 33707167
Part Fibre Toxicol. 2021 Nov 22;18(1):41
pubmed: 34809667
Clin Chest Med. 2020 Dec;41(4):709-722
pubmed: 33153689
Chest. 2020 Sep;158(3):1060-1068
pubmed: 32563682
Dis Chest. 1969 Apr;55(4):274-8
pubmed: 5775743
MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):813-818
pubmed: 31557149
Int J Occup Environ Health. 2014 Jan-Mar;20(1):26-32
pubmed: 24804337
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Ann Am Thorac Soc. 2018 Dec;15(12):1404-1410
pubmed: 30188758
Front Immunol. 2016 Mar 11;7:97
pubmed: 27014276
Chest. 2012 Aug;142(2):419-424
pubmed: 22383661
J Comput Assist Tomogr. 2016 Nov/Dec;40(6):923-927
pubmed: 27680410
Int J Environ Res Public Health. 2019 Apr 02;16(7):
pubmed: 30986926
Eur Respir J. 2017 Sep 11;50(3):
pubmed: 28893868
AJR Am J Roentgenol. 2007 Dec;189(6):1402-6
pubmed: 18029877
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
pubmed: 742764
Int J Environ Res Public Health. 2019 Feb 16;16(4):
pubmed: 30781462
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Scand J Work Environ Health. 2019 May 1;45(3):280-288
pubmed: 30448860
Am J Public Health. 2015 Aug;105(8):1543-51
pubmed: 26066912